Is ICPBF or JNJ a better dividend investment in 2026?

ICPBF currently yields 3591.84% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ICPBF offers higher current income.

What is the dividend yield difference between ICPBF and JNJ?

ICPBF has a forward dividend yield of 3591.84% ($0.88/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 3588.48 percentage points.

Home › Compare › ICPBF vs JNJ

ICPBF vs JNJ: Dividend Comparison 2026

ICPBF yields 3591.84% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ICPBF wins by $2546472451476.38M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ICPBF

● Live price

3591.84%

Share price

$0.02

Annual div

$0.88

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2546472451476.40M

Annual income

$2,414,250,512,578,594,300.00

Full ICPBF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ICPBF vs JNJ

📍 ICPBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ICPBF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ICPBF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ICPBF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ICPBF

Annual income on $10K today (after 15% tax)

$305,306.12/yr

After 10yr DRIP, annual income (after tax)

$2,052,112,935,691,805,200.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ICPBF beats the other by $2,052,112,935,691,804,400.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ICPBF + JNJ for your $10,000?

ICPBF: 50%JNJ: 50%

100% JNJ50/50100% ICPBF

Portfolio after 10yr

$1273236225738.21M

Annual income

$1,207,125,256,289,297,700.00/yr

Blended yield

94.81%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ICPBF

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ICPBF buys

JNJ buys

No recent congressional trades found for ICPBF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricICPBFJNJ

Forward yield	3591.84% ✓	3.36%
Annual dividend / share	$0.88	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$2546472451476.40M ✓	$20.0K
Annual income after 10y	$2,414,250,512,578,594,300.00 ✓	$827.78
Total dividends collected	$2537411291819.20M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ICPBF vs JNJ ($10,000, DRIP)

Year	ICPBF Portfolio	ICPBF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$369,884	$359,183.67	$10,676	$355.77	+$359.2K → ICPBF
2	$12,812,241	$12,416,465.10	$11,407	$389.39	+$12.80M → ICPBF
3	$415,661,028	$401,951,930.81	$12,198	$426.53	+$415.65M → ICPBF
4	$12,631,974,815	$12,187,217,514.69	$13,056	$467.62	+$12631.96M → ICPBF
5	$359,656,961,315	$346,140,748,262.50	$13,987	$513.12	+$359656.95M → ICPBF
6	$9,595,395,791,041	$9,210,562,842,434.92	$14,998	$563.56	+$9595395.78M → ICPBF
7	$239,922,554,534,206	$229,655,481,037,791.62	$16,098	$619.52	+$239922554.52M → ICPBF
8	$5,623,341,779,859,856	$5,366,624,646,508,255.00	$17,295	$681.69	+$5623341779.84M → ICPBF
9	$123,571,905,511,971,460	$117,554,929,807,521,400.00	$18,599	$750.82	+$123571905511.95M → ICPBF
10	$2,546,472,451,476,404,000	$2,414,250,512,578,594,300.00	$20,022	$827.78	+$2546472451476.38M → ICPBF

ICPBF vs JNJ: Complete Analysis 2026

ICPBF — Stock

Inscape Corporation, together with its subsidiaries, manufactures office furniture and wall products in the United States and Canada. It operates through two segments, Furniture and Walls. The company offers workstations; storage, including laterals, verticals, and pedestals; lockers and cubbies, specialty storage, laminate casegoods, and nuform shapes; benching; systems; tables, such as coffee, meeting and standing, and height adjustable tables; and task chairs, as well as accessories, such as keyboard trays, and nano and motus monitor arms. It also provides movable walls. The company offers its products through a network of dealers and representatives. Inscape Corporation was founded in 1888 and is headquartered in East Gwillimbury, Canada.

Full ICPBF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ICPBF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ICPBF vs SCHD ICPBF vs JEPI ICPBF vs O ICPBF vs KO ICPBF vs MAIN ICPBF vs ABBV ICPBF vs MRK ICPBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.